| 2-AG | 2-arachidonilglycerol |
| 5-HT | 5-hydroxytryptamine (serotonin) |
| Aβ | Amyloid beta |
| ABA | Abscisic acid |
| AD | Alzheimer’s disease |
| ADAS-Cog | Alzheimer disease assessment scale–cognitive |
| ADAPT | Alzheimer’s disease anti-inflammatory prevention trial |
| ADCS-ADL | Alzheimer’s disease cooperative study-activities of daily living |
| AEA | N-arachidonil-ethanolamine |
| AMPK | Adenosine monophosphate-activated protein kinase |
| APP | Amyloid protein precursor |
| APS | Alzheimer progression score |
| AVL | Auditory Verbal Learning Test |
| BACE1 | β-site APP-cleaving enzyme 1 secretase |
| BADLS | Bristol Activities of Daily Living Scale; |
| BBB | Blood brain barrier |
| BDNF | Brain-derived neurotrophic factor |
| CB1 | G-protein-coupled cannabinoid 1 receptor |
| CB2 | G-protein-coupled cannabinoid 2 receptor |
| CBD | Cannabidiol |
| CCR | Cambridge Contextual Reading Test |
| CD68 | Cluster of Differentiation 68 |
| CDT | Clock Drawing Test |
| CGI-I | Clinical Global Impression-improvement |
| CN | Category naming test |
| CNS | Central nervous system |
| COX | Cyclooxygenase |
| COWA | Controlled Oral Word Association Test |
| CSF | Cerebrospinal fluid |
| DAGLα | Diacylglycerol Lipase alpha |
| DAMPs | Damage-associated molecular patterns |
| DMS | Delayed Matching to Sample |
| DSS | Digit Symbol Substitution |
| ECS | Endocannabinoid system |
| EGCG | Epigallocatechin gallate |
| FAAH | Fatty acid amide hydrolase |
| FMT | Fecal microbiota transplant |
| GABA | Gamma-aminobutyric acid |
| GM | Gut microbiota |
| IFN-γ | Interferon gamma |
| IL-1β | Interleukin 1 beta |
| IN | Intranasal |
| IRS1 | Insulin receptor substate 1 |
| LanCL2 | Lanthionine synthetase C-like protein 2 |
| LDL | Low density lipoprotein |
| LPS | Lipopolysaccharides |
| MAGL | Monoacylglycerol lipase |
| MAPT | MultiDomain Alzheimer preventive trial |
| MCI | Mild cognitive impairment |
| MD | Mediterranean diet |
| MMSE | Mini-mental state examination |
| MoCA | Montreal Cognitive Assessment |
| mTOR | Mammalian target of rapamycin |
| NAPE | N-acyl-phosphatidylethanolamine |
| NTB | Neuropsychological Test Battery |
| NTB | Neuropsychological Test Battery NFTs Neurofibrillary tangles |
| NGF | Nerve growth factor |
| NLR | NOD-like receptors |
| NLRP3 | NLR family pyrin domain containing 3 |
| NPI | Neuropsychiatric Inventory |
| NSAIDs | Non-steroidal anti-inflammatory drugs |
| p70S6K | p70 ribosomal S6 kinase |
| PAL | Paired associate learning scale |
| PAMPs | Pathogen-associated molecular patterns |
| PEA | Palmitoylethanolamide |
| PG | Prostaglandin |
| PPAR-α | Peroxisome proliferator-activated receptor alpha |
| PRRs | Pattern recognition receptors |
| PUFAs | Polyunsaturated fatty acids |
| RANTES | Regulated on Activation, Normal T cell Expressed and Secreted |
| RBANS | Repeatable Battery for the Assessment of Neuropsychological Status |
| RV | Resveratrol |
| SMMSE | Standardized mini-mental state examination |
| T2DM | Type 2 diabetes mellitus |
| TGF-β | Transforming growth factor beta |
| THC | Tetrahidrocannabinol |
| TLRs | Toll-like receptors |
| TNF-α | Tumor necrosis factor alpha |
| WAIS-R | Wechsler Adults Intelligence Scale |
| WMS-R | Wechsler Memory Scale |
| WT | Wild-type |